Conclusions:
This study demonstrates a direct cost saving of £1463.22 per case of
cholesteatoma managed endoscopically. This figure may under-represent
the total cost savings for the patient and the healthcare system as a
whole. This work adds to the building armamentarium of evidence on the
economic advantage of endoscopic ear surgery over a microscopic
approach, and may be helpful to key policy stakeholders and hospitals in
performing a Health Technology Assessment of the endoscopic approach to
ear surgery.